PIK3CA-Related Disorders: From Disease Mechanism to Evidence-Based Treatments

G Morin(Inserm), Guillaume Canaud(Université Paris Cité), Lola Zerbib(Hôpital Necker-Enfants Malades), Antoine Fraissenon(Université Claude Bernard Lyon 1), Vahid Asnafi(Hôpital Necker-Enfants Malades), Estelle Balducci(Hôpital Necker-Enfants Malades), Sophie Kaltenbach(Assistance Publique – Hôpitaux de Paris)
Annual Review of Genomics and Human Genetics
February 5, 2024
10.1146/annurev-genom-121222-114518
Cited by 24

Related Papers

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
|Cell|2016|563
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study
|Blood|2009|269
A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation
|Science Translational Medicine|2014|231
Estrogen Permits Vasopressin Signaling in Preoptic Kisspeptin Neurons in the Female Mouse
|Journal of Neuroscience|2015|94